Kourosh Rezania

Kourosh Rezania practices at The University of Chicago Medical Center in Chicago, Illinois.

Kourosh Rezania's NPI, 1376694356, was assigned on January 16, 2007. Kourosh Rezania holds Illinois license 036101910.

Kourosh Rezania's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Kourosh Rezania's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Kourosh Rezania is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Kourosh Rezania to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kourosh Rezania practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Kourosh Rezania's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Kourosh Rezania is licensed in Illinois.

CMS data shows 469 Medicare services from Kourosh Rezania across 10 procedure codes in 2024, for 255 Medicare patients. Medicare paid $29,603 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 255 Medicare patients who saw Kourosh Rezania in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high blood pressure, and 72% have arthritis. 34% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kourosh Rezania's median patient age at 68, with 56% women.

In 2024, Kourosh Rezania wrote 1,886 Medicare Part D claims for 224 patients. 73% of them were for generic drugs. CMS names the drug for 1,646 of them, across 35 drugs with 11 or more claims each, at $6,789,731 in total drug cost. In 2023, CMS named 1,791 claims across 37 drugs.

Kourosh Rezania accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kourosh Rezania as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 327 general payments to Kourosh Rezania from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Alexion Pharmaceuticals, Inc. paid the most, $51,086.